UV-A1 phototherapy improves nephrogenic fibrosing dermopathy.
Kafi
Reza
R
University of Michigan Medical Center, Ann Arbor 48109, USA.
Fisher
Gary J
GJ
Quan
Taihao
T
Shao
Yuan
Y
Wang
Rui
R
Voorhees
John J
JJ
Kang
Sewon
S
D024042:Collagen Type I / Q000235:genetics; D024061:Collagen Type III / Q000235:genetics; D055513:Connective Tissue Growth Factor; D005260:Female; D005355:Fibrosis; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics; D007674:Kidney Diseases / Q000150:complications*; D007868:Leg Dermatoses / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D012333:RNA, Messenger / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000235:genetics; D053773:Transforming Growth Factor beta1; D014467:Ultraviolet Therapy
C526317:CCN2 protein, human; D024042:Collagen Type I; D024061:Collagen Type III; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D012333:RNA, Messenger; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D055513:Connective Tissue Growth Factor